Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis
<b>Bacground/Objectives</b>: There is limited evidence on the role of glucagon-like peptide-1 receptor agonists in heart failure. We aimed to analyze the clinical efficacy of oral semaglutide in terms of health status and change in body weight in patients with heart failure with reduced...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | Alicia Trenas-Calero, Nuria Prieto-Laín, Miguel A. Pérez-Velasco, Claudia Padilla-Leiva, José M. Pérez-Ruiz, Fátima I. Ruíz-Rodríguez, Ricardo Gómez-Huelgas, María-Rosa Bernal-López, Luis M. Pérez-Belmonte |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2026-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/19/6/894 |
Similar Items
Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study
by: Alicia Trenas-Calero, et al.
Published: (2026-04-01)
by: Alicia Trenas-Calero, et al.
Published: (2026-04-01)
Left Ventricular Remodeling in Patients with Stable Angina Complicated by Heart Failure with Reduced and Preserved Ejection Fraction
by: Denesyuk V., et al.
Published: (2016-09-01)
by: Denesyuk V., et al.
Published: (2016-09-01)
Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)
Relationship between the severity of functional mitral regurgitation at admission and one-year outcomes in patients hospitalized for acute heart failure with mildly reduced ejection fraction
by: Zhenhua Wang, et al.
Published: (2024-07-01)
by: Zhenhua Wang, et al.
Published: (2024-07-01)
Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)
Factors that predict ventricular arrhythmias in the late phase after acute myocardial infarction
by: Kan Saito, et al.
Published: (2021-10-01)
by: Kan Saito, et al.
Published: (2021-10-01)
A method for calculating left ventricular ejection fraction noninvasively from left ventricular arterial coupling (Ees/Ea)
by: Yukiko Yamazaki, et al.
Published: (2023-06-01)
by: Yukiko Yamazaki, et al.
Published: (2023-06-01)
Two-year clinical outcome of patients with mildly reduced ejection fraction after acute myocardial infarction: insights from the prospective KAMIR-NIH Registry
by: Ho Sung Jeon, et al.
Published: (2024-09-01)
by: Ho Sung Jeon, et al.
Published: (2024-09-01)
Low Left-Ventricular Ejection Fraction as a Predictor of Intraprocedural Cardiopulmonary Resuscitation in Patients Undergoing Transcatheter Aortic Valve Implantation
by: Stephen Gerfer, et al.
Published: (2024-03-01)
by: Stephen Gerfer, et al.
Published: (2024-03-01)
Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking
by: Ge Zhang, et al.
Published: (2022-05-01)
by: Ge Zhang, et al.
Published: (2022-05-01)
Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI
by: Ke Shi, et al.
Published: (2023-08-01)
by: Ke Shi, et al.
Published: (2023-08-01)
Combined Prognostic Value of Follow‐Up Ejection Fraction and Natriuretic Peptide Measurements in Heart Failure With Reduced Ejection Fraction Following Initiation of Pharmacotherapy
by: Nandan Kodur, et al.
Published: (2026-06-01)
by: Nandan Kodur, et al.
Published: (2026-06-01)
Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
by: Tamara Pecherina, et al.
Published: (2020-05-01)
by: Tamara Pecherina, et al.
Published: (2020-05-01)
Understanding cardiac systolic performance beyond left ventricular ejection fraction
by: Elena-Laura Antohi, et al.
Published: (2020-04-01)
by: Elena-Laura Antohi, et al.
Published: (2020-04-01)
Left Ventricular Structure is Associated with Postoperative Death After Coronary Artery Bypass Grafting in Patients with Heart Failure with Reduced Ejection Fraction
by: Yan P, et al.
Published: (2022-01-01)
by: Yan P, et al.
Published: (2022-01-01)
The Impact of Sacubitril/Valsartan on Heart Failure Patient with Reduced Left Ventricular Ejection Fraction: Single Center Retrospective Study in Saudi Arabia
by: Al Raddadi S, et al.
Published: (2024-09-01)
by: Al Raddadi S, et al.
Published: (2024-09-01)
Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study
by: Hwajung Kim, et al.
Published: (2024-09-01)
by: Hwajung Kim, et al.
Published: (2024-09-01)
Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
by: Evgenia Koureta, et al.
Published: (2024-02-01)
by: Evgenia Koureta, et al.
Published: (2024-02-01)
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)
Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)
by: Qin-Fen Chen, et al.
Published: (2025-12-01)
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
by: Yang Jiang, et al.
Published: (2024-11-01)
by: Yang Jiang, et al.
Published: (2024-11-01)
Atrial and ventricular ejection force of the fetal heart: Which of the four chambers is the dominant?
by: Elaheh Malakan Rad, et al.
Published: (2019-01-01)
by: Elaheh Malakan Rad, et al.
Published: (2019-01-01)
Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
by: Akito Nakagawa, et al.
Published: (2022-08-01)
by: Akito Nakagawa, et al.
Published: (2022-08-01)
The trajectory of left ventricular ejection fraction in patients with breast cancer — cardio-oncology remains a challenge
by: Maria Joks, et al.
Published: (2025-04-01)
by: Maria Joks, et al.
Published: (2025-04-01)
The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”
by: Kang Fu, et al.
Published: (2024-09-01)
by: Kang Fu, et al.
Published: (2024-09-01)
Ejection Fraction Indexed to Left Ventricular Mass and Its Association With Cardiac Event Risk in a Community Population With Mildly Reduced or Preserved Ejection Fraction
by: Zhongying Zhang, et al.
Published: (2025-06-01)
by: Zhongying Zhang, et al.
Published: (2025-06-01)
EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)
Left Ventricular Strain in Heart Failure with Preserved Ejection Fraction
by: Madhu Shukla, et al.
Published: (2023-01-01)
by: Madhu Shukla, et al.
Published: (2023-01-01)
Predictive factors of left ventricular ejection fraction improvement after myocardial infarction treated invasively
by: Monika Lazar, et al.
Published: (2023-09-01)
by: Monika Lazar, et al.
Published: (2023-09-01)
Automated ejection fraction and risk stratification in cardiomyopathy patients with diverse LV geometry using 2D echocardiography
by: Ziwei Zhu, et al.
Published: (2025-07-01)
by: Ziwei Zhu, et al.
Published: (2025-07-01)
Disparities by Sex, Race, and Ethnicity in Use of Left Ventricular Assist Devices and Heart Transplants Among Patients With Heart Failure With Reduced Ejection Fraction
by: Scott W. Rose, et al.
Published: (2024-01-01)
by: Scott W. Rose, et al.
Published: (2024-01-01)
Outcomes of atherectomy in treating severely calcified coronary lesions in patients with reduced left ventricular ejection fraction: A systematic review and meta-analysis
by: Waiel Abusnina, et al.
Published: (2022-09-01)
by: Waiel Abusnina, et al.
Published: (2022-09-01)
Association of body composition with left ventricular remodeling and outcomes in diabetic heart failure with reduced ejection fraction: assessment of sarcopenic obesity using cardiac MRI
by: Ke Shi, et al.
Published: (2025-02-01)
by: Ke Shi, et al.
Published: (2025-02-01)
The combination of left ventricular ejection fraction and end-diastolic diameter and outcomes in peritoneal dialysis patients: a multicenter retrospective study
by: Jiayin You, et al.
Published: (2025-12-01)
by: Jiayin You, et al.
Published: (2025-12-01)
Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses
by: Xiqiang Wang, et al.
Published: (2022-07-01)
by: Xiqiang Wang, et al.
Published: (2022-07-01)
An Observational Study on the Reversibility of Left Ventricular Diastolic Dysfunction, Impaired Left Ventricular Ejection Fraction and Abnormal Left Ventricular Mass with Levothyroxine Replacement in Primary Hypothyroid Patients of Indian Origin
by: Abhirup Chatterjee, et al.
Published: (2024-12-01)
by: Abhirup Chatterjee, et al.
Published: (2024-12-01)
Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
by: Syuzanna Shahnazaryan, et al.
Published: (2023-07-01)
by: Syuzanna Shahnazaryan, et al.
Published: (2023-07-01)
Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope
by: Ling Guo, PhD, et al.
Published: (2025-03-01)
by: Ling Guo, PhD, et al.
Published: (2025-03-01)
Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
by: Xiu-Yun Jiang, et al.
Published: (2024-04-01)
by: Xiu-Yun Jiang, et al.
Published: (2024-04-01)
Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction
by: Victor Chien‐Chia Wu, et al.
Published: (2020-10-01)
by: Victor Chien‐Chia Wu, et al.
Published: (2020-10-01)
Similar Items
-
Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study
by: Alicia Trenas-Calero, et al.
Published: (2026-04-01) -
Left Ventricular Remodeling in Patients with Stable Angina Complicated by Heart Failure with Reduced and Preserved Ejection Fraction
by: Denesyuk V., et al.
Published: (2016-09-01) -
Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01) -
Relationship between the severity of functional mitral regurgitation at admission and one-year outcomes in patients hospitalized for acute heart failure with mildly reduced ejection fraction
by: Zhenhua Wang, et al.
Published: (2024-07-01) -
Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)
